Ash K, Author at BioPharmaJournal - Page 4 of 4

Home Authors Posts by Ash K

39 POSTS 0 COMMENTS

Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC,...

Ash K - December 2, 2021 0

The US FDA Approves The Expanded Manufacturing Process Of ADMA Biologics...

Ash K - May 11, 2021 0

Seagen Inc. (NASDAQ:SGEN) Announce Positive CHMP Opinion For TUKYSA For Treating...

Ash K - December 31, 2020 0

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Reports Study Results Showing Effectiveness of Mino-Lok...

Ash K - December 21, 2020 0

Myovant Sciences (NYSE:MYOV) Announces Second Quarter Fiscal 2020 Financial Results and...

Ash K - December 18, 2020 0

Acorda Therapeutics Inc. (NASDAQ:ACOR) Reports $27.3 Million Net Revenu From AMPYRA®...

Ash K - November 12, 2020 0

Aytu Bioscience Inc (NASDAQ:AYTU) Reports An Impressive Fiscal Q4 2020 Performance

Ash K - October 21, 2020 0

Aptorum Group Limited (NASDAQ:APM) Unveils Infectious Disease Liquid Biopsy Subsidiary to...

Ash K - October 14, 2020 0

Myovant Sciences (NYSE:MYOV) Launches A Grant Program, “Forward for Health Equity”...

Ash K - October 2, 2020 0

1 2 34Page 4 of 4

Recent Post

QQQ stock chart

Invesco QQQ Trust Series 1 (NASDAQ:QQQ) continues higher as banking fears...

Ash K - March 30, 2023 0

The QQQ’s are finally starting to hold above the major $309 level and are continuing higher this morning. Bank fears are being...

Banking stocks in focus

Stocks in Focus as short interest rises (TTCF,BYND,ALLO,EDIT,SANA,ARQT,IBRX)

March 28, 2023

Banking stocks in focus

Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future...

March 24, 2023

GameStop (NYSE:GME) shorts could to be crushed by Apes

March 21, 2023

Banking stocks in focus

Axon Enterprise Inc (NASDAQ:AXON) keep surging and here’s why

March 19, 2023